MEDICINOVA INC(MNOV)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
MEDICINOVA INC (MNOV) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MNOV at 13.0/100 on a 32-signal composite quality model, placing it at rank #2,878 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), MEDICINOVA INC reports quarterly revenue of $458.4K, net income of $-2.3M, free cash flow of $-1.9M. Top institutional holders of MNOV by reported 13-F value include Essex Woodlands Management, BlackRock, CITIGROUP, based on the most recent SEC filings. MNOV trades on the Nasdaq exchange and files with the SEC under CIK 1226616. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MNOV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MEDICINOVA INC directly from SEC EDGAR.
AI Quality Score
13.0/100
AI Rank
#2,878
Revenue
$458.4K
Net Income
$-2.3M
Free Cash Flow
$-1.9M
MNOV key financials by period
MEDICINOVA INC reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$409.7K
$-12.0M
—
FY 2023
10-K
$1.0M
$-8.6M
—
FY 2021
10-K/A
$4.0M
$-10.1M
—
FY 2013
10-K
$2.4M
$-4.0M
-170.1%
FY 2012
10-K
$2.4M
$-264.9M
—
FY 2011
10-K
$1.6M
$-253.9M
—
Institutions holding MNOV
Institutional investors reporting a position in MEDICINOVA INC on SEC Form 13F.
